Todd Harris reports 2.91M shares in Tyra Biosciences (TYRA)
Rhea-AI Filing Summary
Tyra Biosciences reports a Schedule 13G/A showing beneficial ownership by Todd Harris. As of March 31, 2026, the company reported 59,469,687 shares outstanding. The Reporting Person beneficially owns 2,913,342 shares, or 4.8% of the class, consisting of 1,358,631 shares held directly and 1,554,711 shares underlying options exercisable within 60 days.
The filing confirms sole voting and dispositive power over all 2,913,342 shares.
Positive
- None.
Negative
- None.
Insights
Majority of reported stake derives from exercisable options, not solely held shares.
The filing shows 2,913,342 shares beneficially owned as of March 31, 2026, representing 4.8% of 59,469,687 shares outstanding. Of that position, 1,554,711 shares are underlying options exercisable within 60 days, which is material to voting and disposal calculations.
Outcome depends on whether options are exercised; subsequent disclosures will show any change in float or voting if exercises occur.
Holding size is below 5% reporting threshold but shows near‑term potential issuance from option exercise.
The reported 4.8% stake is under 5% and therefore routine for Schedule 13G/A treatment. The inclusion of 1,554,711 exercisable options means the economic and voting exposure could change if exercised within the 60‑day window referenced.
Market impact will depend on whether the options are exercised and whether any shares are sold; filings after exercise would disclose changes.
Key Figures
Key Terms
beneficial ownership regulatory
options exercisable within 60 days financial
sole dispositive power regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.